Skip to main content
Caplight Logo









Zetta Genomics Ltd

Zetta Genomics Ltd

Private
CambridgeHealthcare & Life Scienceshttps://zettagenomics.com/

Last Round

Seed

Feb 8, 2024

Total Funding Raised

$10.28M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Zetta Genomics Ltd is a genomic data technology company that provides the XetaBase platform for large-scale genomic data management and analysis to enable precision medicine.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Infrastructure

Keywords

genomic data managementbioinformatics platformgenomic data analysisprecision medicinegenomic databasetertiary analysisvariant annotationgenomic infrastructurebioinformatics pipelinegenomics techclinical genomicsgenomic data platformSaaSgenomic data lakebioinformatics software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Zetta Genomics Ltd Comparables

Compare Zetta Genomics Ltd with similar companies based on industry and business-model similarity.

Zetta Genomics Ltd comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genestack
85%
Lifebit
79%
SeqOne
75%

Zetta Genomics Ltd Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 8, 2024
SeedApr 18, 2023
SeedFeb 2, 2022

Key People

Founding team and executive leadership

Ignacio Medina

Founder, CEO And CTO At Zetta Genomics

Founding Team

Bryony Burrows

Chief Operating Officer, Chief Financial Officer

Executive Team

Zetta Genomics Ltd Investors

Notable investors and investment history

Zetta Genomics Ltd investors
InvestorRounds
Nina CapitalSeed
We Venture CapitalSeed
APEX VenturesSeed
Cambridge EnterpriseSeed
青創同行 We VentureSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 7, 2026

    Acquired key assets from UK-based healthcare technology partner Zetta Genomics.

  • Sep 18, 2025

    Shortlisted for two awards at the UK Tech Awards 2025.

Zetta Genomics Ltd Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Zetta Genomics Ltd Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Zetta Genomics Ltd's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge
Employee Range15
Year Founded2018
Last FundingFeb 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?